[Inhibition of lipolysis by alpha and beta sympatholytics, nicotinic acid and prostaglandin E1].
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004983:Ethanolamines / Q000494:pharmacology; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D004983:Ethanolamines; D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D011453:Prostaglandins; D013565:Sympatholytics; D010643:Phenoxybenzamine; D000324:Adrenocorticotropic Hormone; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D010646:Phentolamine
Hemmung der Lipolyse durch alpha- und beta-Sympathicolytica, Nicotinsäure und Prostaglandin E1.